Quality of life in patients with thalassemia major and intermedia in Kerman-Iran (I.R.)

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 4, Issue 1, 2012, Pages

  Safizadeh, Hossein ^a   Farahmandinia, Zahra ^b   nejad, Simin Soltani ^c   Pourdamghan, Nasim ^d   Araste, Majid ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Iranian Thalassemia Society   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFEROXAMINE; IRON CHELATING AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENERAL HEALTH STATUS ASSESSMENT; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PATIENT CARE; PHYSICAL CAPACITY; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; SOCIAL STATUS; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; VITALITY;

EID: 85002349604     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2012.058     Document Type: Article

References (13)

1. Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol B. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disorders. 2010;10:1. http://dx.doi.org/10.1186/1471-2326-10-1 PMid:20180983 PMCid:2836992.
2. Roudbari M, Soltani-Rad M, Roudbari S. The survival analysis of beta thalassemia major patients in South East of Iran. Saudi Med J. 2008;29:1031-1035. PMid:18626536.
3. Dahui M, Hishamshan MI, Rahman AJA, Aljuid SM. Quality of life in transfusion- dependent thalassaemia patients on desferrioxamine treatment. Singapore medj. 2009;50:794-799. PMid:19710979.
4. Levine L, Levine M. Health care transition in thalassemia: pediatric to adult-oriented care. Ann N Y Acad Sci. 2010;1202:244-247. http://dx.doi.org/10.1111/j.1749- 6632.2010.05598.x PMid:20712800.
5. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann NY Acad Sci. 2005;1054:457-461. http://dx.doi.org/10.1196/annals.1345.059 PMid:16339697.
6. Telfer P, Coustantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann NY Acad Sci. 2005;1054:273-282. http://dx.doi.org/10.1196/annals.1345.035 PMid:16339675.
7. Brazier E, Harper R, Jones N M, O'Cathain A, Thomas K J, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160-164. http://dx.doi.org/10.1136/bmj.305.6846.160 PMid:1285753 PMCid:1883187.
8. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey(SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005;14:875-882. http://dx.doi.org/10.1007/s11136-004-1014-5 PMid:16022079.
9. Jafari H, Lahsaeizadeh S, Jafari P, Karimi M. Quality of life in thalassemia major: Reliability and validity of the Persian version of the SF-36 questionnaire. J Postgrad Med 2008;54:273-275. http://dx.doi.org/10.4103/0022-3859.41432 PMid:18953145.
10. Azarkeivan A, Hajibeig B, Alavian SM, Moghani Lankarani M, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia. JRMS. 2009;14:349-355. PMid:21772908 PMCid:3129078.
11. Hadi N, Karami D, Montazeri A. Health-related quality of life in major thalassemic patients. Payesh. 2009;8:387-393.[Persian].
12. Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in malaysian childran with thalassamia. Health and Quality of life Outcomes. 2006;4:39. http://dx.doi.org/10.1186/1477-7525-4-39 PMid:16813662 PMCid:1538578.
13. Osborne RH, De Abreu Lourenço R, Dalton A, Houltram J, Dowton D, Joshua DE, Lindeman R, Ho PJ. Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study. Value Health. 2007;10:451-456. http://dx.doi.org/10.1111/j.1524-4733.2007.00200.x PMid:17970927.